Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
narcolepsy
Pharma
JPM25: Takeda touts 6 pipeline assets with big sales potential
At JPM, Takeda CEO Christophe Weber said the company is focused on six pipeline assets that could each reel in blockbuster-level sales down the line.
Fraiser Kansteiner
Jan 15, 2025 3:17pm
After trial win, Axsome eyes FDA filing for narcolepsy hopeful
Nov 27, 2024 9:46am
Takeda, WuXi, LianBio—Fierce Pharma Asia
Feb 16, 2024 8:24am
Drug mix-up prompts Azurity to recall 1 lot of Zenzedi
Jan 26, 2024 9:41am
FDA faces lawsuit from Jazz after approval of Avadel's sleep aid
Jun 23, 2023 11:38am
FDA endorses Avadel's Lumryz, a major threat to Jazz's Xyrem
May 2, 2023 8:00am
